CST2 is activated by RUNX1 and promotes pancreatic cancer progression by activating PI3K/AKT pathway
Archives of Biochemistry and Biophysics · 2023
DOI: 10.1016/j.abb.2023.109760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2023. Verfasst von Rongwen Ou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350001, China; Fujian Abdom…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350001, China; Fujian Abdominal Surgery Research Institute, The First Affiliated Hospital, Fujian…
Zitieren
APA
Ou, R., Lin, C., & Chen, Y. (2023). CST2 is activated by RUNX1 and promotes pancreatic cancer progression by activating PI3K/AKT pathway. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2023.109760
Vancouver
Ou R, Lin C, Chen Y. CST2 is activated by RUNX1 and promotes pancreatic cancer progression by activating PI3K/AKT pathway. Archives of Biochemistry and Biophysics. 2023. doi:10.1016/j.abb.2023.109760
BibTeX
@article{Ou2023,
author = {Ou, Rongwen and Lin, Chengjie and Chen, Youting},
title = {CST2 is activated by RUNX1 and promotes pancreatic cancer progression by activating PI3K/AKT pathway},
journal = {Archives of Biochemistry and Biophysics},
year = {2023},
doi = {10.1016/j.abb.2023.109760}
}
EUVIMED